Better Home & Finance Holding Company Announces Fourth Quarter and Full Year 2023 Results
Reporting first annual financial results as a public company, after closing business combination in August 2023, which unlocked approximately $565...
Month: March 2024
Better Home & Finance Holding Company Announces Fourth Quarter and Full Year 2023 Results
Reporting first annual financial results as a public company, after closing business combination in August 2023, which unlocked approximately $565...
atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights
NEW YORK and BERLIN, March 28, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”) a clinical-stage biopharmaceutical...
ARKO Corp. Negotiates Enhanced Value for Stockholders in Final Payment for TEG Acquisition
RICHMOND, Va., March 28, 2024 (GLOBE NEWSWIRE) -- ARKO Corp. (Nasdaq: ARKO) (“ARKO” or the “Company”), a Fortune 500 company...
Apollomics Highlights Clinical Progress and Reports Full Year 2023 Financial Results
FOSTER CITY, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late- stage...
Apollomics Highlights Clinical Progress and Reports Full Year 2023 Financial Results
FOSTER CITY, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late- stage...
Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing
Announces strategic portfolio reprioritization focused on rapid advancement of clinical-stage programs for XTX301, a tumor-activated, IL-12, and XTX101, a tumor-activated,...
Walgreens Boots Alliance Reports Fiscal 2024 Second Quarter Results
Second quarter operational results in line with expectations, U.S. Healthcare achieved adjusted EBITDA profitability, narrowing full-year adjusted EPS guidance range...
Telesat Reports Results for the Quarter and Twelve Months Ended December 31, 2023
OTTAWA, March 28, 2024 (GLOBE NEWSWIRE) -- Telesat (NASDAQ and TSX: TSAT), one of the world’s largest and most innovative...
Tilray Brands, Inc. to Announce Third Quarter 2024 Financial Results on April 9, 2024
NEW YORK and LEAMINGTON, Ontario, March 28, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY;...
Stran & Company Reports 28.7% Increase in Sales and Achieves Profitability for the 2023 Fiscal Year
Benefitting from Increased Operating Efficiency and Economies of Scale, Evidenced by 156% Year-Over-Year Increase in Operating Income for the Fourth...
Stran & Company Reports 28.7% Increase in Sales and Achieves Profitability for the 2023 Fiscal Year
Benefitting from Increased Operating Efficiency and Economies of Scale, Evidenced by 156% Year-Over-Year Increase in Operating Income for the Fourth...
Syndax Announces Completion of Enrollment in AUGMENT-101 Pivotal Trial Cohort of Patients with Relapsed/Refractory mNPM1 Acute Myeloid Leukemia
– Topline data expected in 4Q24 could support sNDA filing in 1H25 – – Revumenib has the potential to address...
GenFleet and BeiGene Enter into Trial Collaboration for a Potentially First-in-class Combination Therapy to Initiate Phase Ib/II Study of GFH009 (CDK9 inhibitor) and BRUKINSA® (zanubrutinib) Treating Diffuse Large B Cell Lymphoma
SHANGHAI, March 28, 2024 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today...
Shimmick Corporation Announces Fourth Quarter and Fiscal Year 2023 Results
IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Shimmick Corp. (NASDAQ: SHIM), a leading water infrastructure company, today announced financial...
Gogo Testing for Global Broadband Antenna Achieves Major Milestone
Gogo Galileo Remains on Track for Commercial Launch Later This Year BROOMFIELD, Colo., March 28, 2024 /PRNewswire/ -- Gogo Business...
REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMD
ROCKVILLE, Md., March 28, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced the publication of results from the Phase...
Mannatech Reports Financial Results for Fourth Quarter and Full Year 2023
Contacts Erin K. Barta General Counsel and Corporate Secretary 972-471-7742 ir@mannatech.com www.mannatech.com Mannatech, Incorporated (NASDAQ: MTEX), a global health and...
Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments
WILMETTE, Ill., March 28, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing...
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Contacts IR and PR Rob Windsor Rwindsor@serestherapeutics.com Seres Therapeutics, Inc. (Nasdaq: MCRB) (“Seres” or the “Company”), a leading microbiome therapeutics...
Manhattan Bridge Capital, Inc. Announces Payment of Quarterly Dividend
GREAT NECK, N.Y., March 28, 2024 (GLOBE NEWSWIRE) -- Manhattan Bridge Capital, Inc. (NASDAQ: LOAN) announced today that, in accordance...
Laser Photonics’ CleanTech Simplifies Gas Tank Cleaning in Motorcycle Repair & Restoration
Contacts Investor Relations Contact: laser@haydenir.com Contact: Karla Kizzort Marketing Specialist Laser Photonics Corporation kkizzort@laserphotonics.com Laser Photonics Corporation (LPC), a leading...
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
WALTHAM, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company on a mission to protect...
Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
--Resubmission of NDA On Track for Early Q2 24—--Cash Runway into 2025, including through Potential FDA Approval in Early Q4...
InterSystems and IPA’s Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare Applications
Contacts investors@ipatherapeutics.com IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), InterSystems, a creative data technology provider dedicated to...
Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates
MALVERN, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a...
Gogo Testing for Global Broadband Antenna Achieves Major Milestone
Gogo Galileo Remains on Track for Commercial Launch Later This Year BROOMFIELD, Colo., March 28, 2024 /PRNewswire/ -- Gogo Business...
Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
— Gilead Granted Exclusive License to Xilio’s Tumor-Activated IL-12 Program, Including XTX301, a Clinical-Stage IL-12 Molecule with Potential to Treat...
J.D. Power Names Fifth Third Bank No. 1 for Retail Banking Experience in Florida
Contacts Beth Oates (Media Relations) Beth.Oates@53.com | 313-230-9002 Matt Curoe (Investor Relations) Matthew.Curoe@53.com | 513-534-2345 J.D. Power today named Fifth...
FinWise Bancorp Appoints Jim Noone President and Hires Robert Wahlman as Chief Financial Officer
MURRAY, Utah, March 28, 2024 (GLOBE NEWSWIRE) -- FinWise Bancorp (NASDAQ: FINW) (“FinWise” or the “Company”), parent company of FinWise...
ECARX Partners with Lianyou Zhilian to Accelerate Development of Intelligent Vehicle Solutions
SHANGHAI, China, March 28, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility...
Data Storage Corporation Reports Record Revenue of $25 Million and Achieves Profitability for the 2023 Fiscal Year
MELVILLE, N.Y., March 28, 2024 (GLOBE NEWSWIRE) -- Data Storage Corporation (Nasdaq: DTST) (“DSC” and the “Company”), a provider of...
Data Storage Corporation Reports Record Revenue of $25 Million and Achieves Profitability for the 2023 Fiscal Year
MELVILLE, N.Y., March 28, 2024 (GLOBE NEWSWIRE) -- Data Storage Corporation (Nasdaq: DTST) (“DSC” and the “Company”), a provider of...
Canadian Solar Comments on Complaint Filed by Maxeon Solar
GUELPH, ON, March 28, 2024 /PRNewswire/ -- Canadian Solar Inc. (the "Company", or "Canadian Solar") (NASDAQ: CSIQ), today issued the following...
Criteo Secures Its First MRC Accreditation for Retail Media Measurement
Now accredited for impression and click metrics across desktop, mobile web, and mobile in-app environments NEW YORK, March 28, 2024...
CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS AND FINANCIAL RESULTS
BEIJING, March 28, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and...
CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates
Enrollment in CARPO, Phase 2b trial of Auxora™ in acute pancreatitis (AP), on track with topline data expected in 2Q...
Aldeyra Therapeutics Announces Clinical Development Plan for Resubmission of New Drug Application for Reproxalap in Dry Eye Disease
Contacts Investor & Media: David Burke Tel: (917) 618-2651 investorrelations@aldeyra.com Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted...
Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates
MALVERN, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a...
Mayfair Gold Commences 2024 Environmental Field Program at Fenn-Gib Gold Project
MATHESON, Ontario, March 28, 2024 (GLOBE NEWSWIRE) -- Mayfair Gold Corp. (“Mayfair” or the “Company”) (TSX-V: MFG; OTCQB: MFGCF) today...